Insider buying last 90 days
No open-market insider purchases were filed for EYE in the last 90 days.
From Form 4 filings, dated to when each was filed.
Oct 12 close
This week's attention on National Vision centers on its Q2 2026 results and the path toward the next earnings report. The company beat adjusted EPS consensus with $0.25 against an expected $0.18, raised its fiscal 2026 adjusted EPS guidance, and maintains a "Moderate Buy" consensus among eleven analysts with an average 12-month price target significantly above its current trading price. Separately, the company launched its 2026-2027 scholarship program for optometry students, offering up to $7,500 per award.
National Vision trades at $17.07, up 2.3% on the day, but remains below both its 50-day average of $18.00 and 200-day average of $22.02, with the 50-day below the 200-day. Shares sit 15.1% lower over three months and 37.7% lower over the past year, near the 52-week low of $14.75. The GekkoIndex reads 57.7, placing the stock in the Neutral zone, down 3.7 over five days. Fair value is estimated at $22.00, a gap of -22.4% from the current price.
Earnings are scheduled for 4 November 2026, 23 days away, falling inside a typical 20-trading-day holding window; the prior report saw a -13.6% reaction despite the EPS beat, against an average absolute reaction of 10.9%. Smart money data shows no insider, Congress, or unusual options activity in their respective windows, though one billionaire holder and one trailblazer holder are recorded. Seasonality from this point has averaged +11.6% over the next 20 trading days across 5 years, rising in 4 of them.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
National Vision scores 2 supportive, 1 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed2 headwinds
Below 50 and 200-day
Close $17.07 is below the 50-day ($18.00) and 200-day ($22.02) averages, and the 50-day is below the 200-day.
See the chart57.7, Neutral
Reading 57.7 is in the Neutral zone.
See the GekkoIndex22.4% below
Price is 22.4% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 23 days
Reports on Nov 4, 2026, 23 days away — inside a typical 20-trading-day hold.
See earnings+11.6% on average
From this point in the calendar, the next 20 trading days averaged +11.6% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
National Vision closed at $17.07 on Oct 12, 2026, −37.7% over the past year, inside a 52-week range of $14.75 to $30.02.
Use the left and right arrow keys to read daily values.
Put EYE on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
National Vision sells eyewear and related vision care to consumers across the United States through a group of retail subsidiaries. Its offerings span eyeglasses, contact lenses, and optical accessories, alongside eye exams and optometric services delivered at its branded store locations. These stores operate under several names, including America's Best, Eyeglass World, Vista Optical, Fred Meyer, Vista Optical military, and Vision Center.
The business is split into two segments, Owned & Host and Legacy, and it also provides health maintenance organization services tied to vision benefits. As of January 1, 2022, National Vision ran 1,278 physical stores and supplemented that network with several online retail platforms, giving customers both in-person and digital ways to shop for eyewear and arrange eye care.
The company traces back to its founding in 1990 and runs its operations from headquarters in Duluth, Georgia. Its shares trade on the NASDAQ under the ticker EYE.
National Vision’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 57.7, in the Neutral zone, down 3.7 points over five sessions.
Down 3.7 points over five sessions, from the Accumulation zone.
Reading for Oct 12, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 52 | −0.2% | −0.5% | ||
| Accumulation | 267 | +0.6% | +3.1% | ||
| Neutral (current zone) | 318 | −0.3% | −1.2% | ||
| Distribution | 39 | +0.8% | +0.9% | ||
| Selling | 6 | Too few readings yet | |||
Average EYE share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
National Vision trades 22.4% below Gekko Fair Value of $22.00, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what National Vision shares are worth, recalculated every trading day.
$22.00
Gekko Fair Value, Oct 10, 2026
22.4% Undervalued
At the end of Aug 2026 the price was 33.3% below the estimate.
No open-market insider purchases were filed for National Vision, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for EYE in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in EYE were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
National Vision has been buying back its own shares.
From company filings.
2of the funds Gekko tracks hold EYE.
National Vision reports on Nov 4, 2026, before the open (23 days away), and beat the EPS estimate in 8 of its last 8 reports.
Nov 4, 2026
Expected before the open, 23 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 12, 2026 | $0.25 est $0.18 | $498.8M est $499.1M | −13.6% |
| May 13, 2026 | $0.45 est $0.43 | $543.9M est $545.1M | −15.4% |
| Mar 4, 2026 | $0.15 est $0.06 | $503.4M est $495.3M | +9.2% |
| Nov 5, 2025 | $0.13 est $0.12 | $487.3M est $495.1M | −8.3% |
| Aug 6, 2025 | $0.18 est $0.13 | $486.4M est $471.3M | −2.6% |
| May 7, 2025 | $0.34 est $0.31 | $510.3M est $466.4M | +25.1% |
| Feb 26, 2025 | −$0.04 est −$0.05 | $437.3M est $437.0M | +8.1% |
| Nov 6, 2024 | $0.12 est $0.06 | $451.5M est $432.8M | −4.7% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for National Vision is $28.18, +65.1% from the last close, from 10 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 10 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 11 | Guggenheim | $27 | +58.2% |
| Sep 10 | Barclays | $27 | +58.2% |
| Aug 31 | Jefferies | $31 | +81.6% |
| Aug 13 | Morgan Stanley | $21 | +23.0% |
| Aug 13 | Roth MKM | $27 | +58.2% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Oct 10, National Vision averaged +11.6% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +4.1% | 5 of 5 |
| Next 10 trading days | +3.8% | 3 of 5 |
| Next 15 trading days | +6.4% | 5 of 5 |
| Next 20 trading days | +11.6% | 4 of 5 |
| Next 30 trading days | +12.0% | 4 of 5 |
For scale, EYE’s typical 20-trading-day move in either direction is about 9.4%.
National Vision’s market cap is $1.37B, with a P/E ratio of 27.1 and revenue of $2.03B over the last twelve months.
Coverage of National Vision this week reads neutral: 1 positive, 4 neutral and 0 negative headlines.
National Vision’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| WMTWalmart | Neutral | 2.5% below |
| COSTCostco Wholesale | Neutral | 16.4% above |
| ORLYO'Reilly Automotive | Neutral | 4.7% below |
| TGTTarget | Accumulation | 5.7% above |
| CVNACarvana | Accumulation | 19.7% below |
| AZOAutoZone | Neutral | 28.5% below |
A peer links to its own page where one exists.
National Vision’s market cap is $1.37B at the Oct 12, 2026 close of $17.07, with 79.07M shares outstanding. The shares trade on a P/E ratio of 27.1.
The consensus analyst 12-month price target for National Vision is $28.18, +65.1% from the last close. Of the 10 firms that rated the stock in the last 90 days, 8 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate National Vision is undervalued: the Oct 12, 2026 close of $17.07 is 22.4% below Gekko Fair Value of $22.00. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
National Vision is expected to report on Nov 4, 2026, before the market opens (23 days away). Analysts expect earnings of $0.17 per share on revenue of $512.7M. National Vision beat the earnings estimate in 8 of its last 8 reports, moving 10.9% on average across the report.
National Vision’s 52-week high is $30.02 and its 52-week low is $14.75; it closed at $17.07 on Oct 12, 2026, −37.7% over the past year. Over the last five years the shares peaked at $65.92 on Nov 5, 2021.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (fair value and seasonality), 1 as mixed (gekkoindex) and 2 as headwinds (trend and earnings risk). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.